Latest Breaking News On - Maintain nasdaq - Page 1 : comparemela.com

Synaptogenix Announces Reverse Stock Split to Maintain Nasdaq Listing

Synaptogenix Announces Reverse Stock Split to Maintain Nasdaq Listing
lelezard.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from lelezard.com Daily Mail and Mail on Sunday newspapers.

Pacific stock transfer companyDrug administrationExchange commissionSynaptogenix incPrnewswire synaptogenix incAnnounces reverse stock splitMaintain nasdaqStandard timeNasdaq capital marketNasdaq capitalOrphan drug designation

Form DEF 14A TENAX THERAPEUTICS, INC For: Oct 12

Form DEF 14A TENAX THERAPEUTICS, INC For: Oct 12
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

United statesDistrict of columbiaNew yorkNorth carolinaState of delawareGlen lennoxChapel hillRobynm hunterGeraldt proehlEliot lurierEliotm lurierChristopher giordanoJune almenoffDeclan dooganMichael davidsonChristophert giordano

Soligenix On Track to Deliver Important Front-Line Treatment to US Market in 2024

Soligenix On Track to Deliver Important Front-Line Treatment to US Market in 2024
jcnnewswire.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from jcnnewswire.com Daily Mail and Mail on Sunday newspapers.

Japan corporate news networkBiomedical advanced researchDevelopment authorityDigital soligenix incDigital holdingsProducts developmentSoligenix incAdvisory incSoligenix on trackDeliver important front line treatmentSeeks approvalReverse stock splitMaintain nasdaqSoligenix presidentChief executive officerChristopher schaber

Soligenix, Inc: Soligenix On Track to Deliver Important Front-Line Treatment to US Market in 2024

Company Seeks Approval for Reverse Stock Split to Maintain Nasdaq ListingNEW YORK, NY, Jan 16, 2023 - (ACN Newswire) - PCG Digital Soligenix, Inc. (Nasdaq: SNGX), a late-stage biopharmaceutical company

Biomedical advanced researchDevelopment authorityDigital soligenix incDigital holdingsProducts developmentSoligenix incDigitalsoligenix incAdvisory incSeeks approvalReverse stock splitMaintain nasdaqSoligenix presidentChief executive officerChristopher schaberOrphan products development

acnnewswire.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from acnnewswire.com Daily Mail and Mail on Sunday newspapers.

Christopher schaberBiomedical advanced researchDevelopment authorityDigital soligenix incDigital holdingsProducts developmentSoligenix incAdvisory incDeliver important front line treatmentSeeks approvalReverse stock splitMaintain nasdaqSoligenix presidentChief executive officerOrphan products developmentAcn newswire